Sinus Dilation Device Market: Current Analysis and Forecast (2022-2028)

Sinus Dilation Device Market: Current Analysis and Forecast (2022-2028)

The sinus dilation device market is expected to register a CAGR of approx. 7% over the period of 2022-2028. Sinusitis is a medical condition that causes inflammation along the sinus lining, which can cause symptoms like facial pain, sinus headaches, breathing problems, fatigue, tooth pain, and a loss of taste and smell. To treat nasal sinus drainage problems or sinusitis, medical devices known as sinus dilation devices are used to enlarge the sinus openings of a patient's nose. One of the advanced sinus dilation procedures is balloon sinus dilation, a minimally invasive procedure that replaces traditional sinus surgery. A doctor uses inflated balloons to reshape the patient's sinus pathway in order to open the blocked sinus or nasal pathway during a balloon sinus dilation procedure. Due to its immediate and long-lasting effects, the procedure is typically preferred over decongestants, antibiotics, or steroids. The growing demand for sinus dilation devices can be attributed to the increasing prevalence of chronic rhinosinusitis across the globe. For instance, according to the World Allergy Organization 2021, the worldwide prevalence of chronic rhinosinusitis (CRS) ranges from about 8% in China, 8.4% in Korea, 11% in Europe, and 12% in the United States. Owing to the glaring statistics due to the rising prevalence of rhinosinusitis which leads to higher sinus surgeries due to which sinus dilation devices boosted across the globe is leading to the growing demand for sinus dilation devices and would contribute to the growth of the market in the forthcoming period as well. Furthermore, the sinus dilation device market is anticipated to grow on account of the high preference for minimally invasive procedures. In addition, increasing awareness among the population about the advantages of balloon sinuplasty over conventional techniques drives the market growth. However, some of the restraints in the market including the availability of non-surgical treatments for chronic sinusitis are impeding the growth of this market all over the world.

• Based on the product, the sinus dilation device market is segmented into balloon sinus dilation devices, endoscopes, functional endoscopic sinus surgery (FESS) instruments set, sinus stents/implants, and others. The balloon sinus dilation devices segment accounted for a significant market share, and it is estimated that it will grow rapidly during the projected timeframe. Balloon sinus dilation devices are safe, small, flexible, and effective in relieving sinusitis symptoms. Due to the fact that the sinus dilation procedure does not involve tissue ablation.
• Based on the procedure, the market is segmented into standalone and hybrid. The standalone segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. Balloon sinus ostial dilation is a stand-alone procedure. In the treatment of chronic rhinosinusitis, standalone balloon dilation is as effective as functional endoscopic sinus surgery.
• Based on the application, the market is fragmented into adult and pediatric. The adult segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. For instance, according to the CDC, 9 out of 10 viral sinusitis cases in adults were observed in the U.S.
• Based on the end-user, the market is segmented into hospitals, ENT clinics, and ambulatory surgical centers (ACSs). The hospital segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to the high volume of surgical procedures performed in hospitals.
• For a better understanding of the market adoption of sinus dilation devices, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the sinus dilation device industry owing presence of highly regulated and developed healthcare infrastructure, the availability of advanced products due to the presence of major market players, and rising healthcare spending in this region.
• Some of the major players operating in Stryker Corporation, Smith & Nephew plc, Olympus Corporation, Medtronic, SinuSys Corporation, KARL STORZ, Sklar Surgical Instruments, Intersect Inc., Johnson & Johnson, Cook Medical. among others. Several M&As along with partnerships have been undertaken.